Causeway Capital Management LLC Purchases 41,476 Shares of Relx Plc (NYSE:RELX)

Causeway Capital Management LLC grew its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 9.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 465,886 shares of the technology company's stock after acquiring an additional 41,476 shares during the quarter. Causeway Capital Management LLC's holdings in Relx were worth $21,161,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. CENTRAL TRUST Co grew its position in Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after purchasing an additional 529 shares during the last quarter. Versant Capital Management Inc purchased a new stake in Relx during the 4th quarter valued at $31,000. Sierra Ocean LLC bought a new stake in shares of Relx in the 4th quarter worth $43,000. Brown Brothers Harriman & Co. raised its stake in shares of Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares during the last quarter. Finally, Private Trust Co. NA boosted its position in shares of Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after buying an additional 199 shares during the last quarter. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have issued reports on RELX. The Goldman Sachs Group initiated coverage on shares of Relx in a research note on Wednesday, March 26th. They set a "buy" rating on the stock. StockNews.com cut shares of Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Morgan Stanley reissued an "overweight" rating on shares of Relx in a report on Wednesday. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Finally, Redburn Atlantic began coverage on Relx in a research report on Wednesday, January 8th. They issued a "buy" rating on the stock. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy".

Relx Price Performance

NYSE RELX traded up $1.00 during trading hours on Friday, reaching $52.20. The company's stock had a trading volume of 718,471 shares, compared to its average volume of 717,339. The company has a market capitalization of $96.61 billion, a price-to-earnings ratio of 28.06, a PEG ratio of 2.73 and a beta of 0.84. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. Relx Plc has a 1 year low of $40.25 and a 1 year high of $52.54. The firm's 50-day moving average price is $49.35 and its 200-day moving average price is $47.97.

Relx Increases Dividend

The business also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be issued a $0.5586 dividend. This is an increase from Relx's previous semi-annual dividend of $0.23. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. Relx's payout ratio is currently 59.68%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.